Etoricoxib
Top View
- COX-2 Selective Non-Steroidal Anti-Inflammatory Drugs For
- Tolerability to Etoricoxib in Patients with Aspirin-Exacerbated Respiratory Disease D Koschel,1 C Ninck Weber,1 G Höffken1,2
- RESEARCH BMJ: First Published As 10.1136/Bmj.B2538 on 14 July 2009
- Results of the Etoricoxib Versus Diclofenac Sodium Gastrointestinal Tolerability and Effectiveness (EDGE) Trial
- Review Article Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: a Systematic Review of Randomized Controlled Trials
- Etoricoxib-Induced Life-Threatening Hyperkalemia and Acute Kidney Dysfunction Against the Background of Telmisartan and a Low Sodium Diet
- Empirical Treatment of Endometriosis
- Indirect Comparison of Nsaids for Ankylosing Spondylitis: Network Meta‑Analysis of Randomized, Double‑Blinded, Controlled Trials
- Questions and Answers on the Review of Etoricoxib-Containing Medicines
- Medications to Be Stopped 3 Weeks Prior to Surgery
- Information for the User
- Appendix A. Pharmacokinetics, Indications and Dosing of Included Drugs
- Risk of Bleeding with Non-Aspirin Non-Steroidal Anti-Inflammatory Drugs Before Spine Procedures Zachary L
- Prescribing Non-Steroidal Anti-Inflammatory Drugs (Nsaids) in Inflammatory Arthritis and Osteoarthritis in Adults
- Challenges and Progress in Nonsteroidal Anti-Inflammatory
- Nonsteroidal Anti-Inflammatory Drugs (Nsaids) and Spontaneous Abortion Pharmacovigilance and Special Access Branch Safety Review
- Cardiovascular Safety of Non-Steroidal Anti-Inflammatory Drugs: Network Meta-Analysis
- 29 Comparison of the Efficacy of Etoricoxib And